Biotest Aktiengesellschaft (BIO) — Strategic Asset Allocation Index

Latest as of June 2023: 148.8%

Biotest Aktiengesellschaft (BIO) has a Strategic Asset Allocation Index of 148.8% as of June 2023. Strategic assets (PP&E of €555.70 Million plus long-term investments of €-) total €555.70 Million, measured against net assets of €373.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Biotest Aktiengesellschaft (BIO) net asset quality to measure how much of total assets are equity-financed.

SAAI

148.8%
Strategic Assets / Net Assets

Strategic Assets

€555.70 Million
PP&E + LT Investments

PP&E

€555.70 Million
EUR

Net Assets

€373.50 Million
EUR

Biotest Aktiengesellschaft Strategic Asset Allocation Index (2013–2021)

This chart shows how Biotest Aktiengesellschaft's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2023, the index stands at 148.8%, representing strategic assets of €555.70 Million against net assets of €373.50 Million EUR. For live market cap and overall valuation, see Biotest Aktiengesellschaft market cap and net worth.

Annual Strategic Asset Allocation Index for Biotest Aktiengesellschaft (2013–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for Biotest Aktiengesellschaft from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Biotest Aktiengesellschaft (BIO) net assets for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2021 125.3% €476.70 Million €476.70 Million €- €380.40 Million ▲ +54.8 pp
2020 70.5% €311.30 Million €311.30 Million €- €441.60 Million ▲ +3.3 pp
2019 67.2% €320.30 Million €320.30 Million €- €476.90 Million ▲ +4.7 pp
2018 62.4% €309.10 Million €307.20 Million €1.90 Million €495.20 Million ▼ -24.1 pp
2017 86.5% €301.00 Million €298.70 Million €2.30 Million €347.80 Million ▲ +30.9 pp
2016 55.7% €200.80 Million €196.50 Million €4.30 Million €360.70 Million ▼ -22.1 pp
2015 77.8% €320.70 Million €317.20 Million €3.50 Million €412.30 Million ▲ +25.4 pp
2014 52.4% €251.40 Million €249.90 Million €1.50 Million €480.20 Million ▲ +0.5 pp
2013 51.9% €238.90 Million €237.10 Million €1.80 Million €460.70 Million
pp = percentage points